Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03227757 · ClinicalTrials.gov registry record · NA
TRILUMINATE Study With Abbott Transcatheter Clip Repair System in Patients With Moderate or Greater TR
A NA study of Tricuspid Valve Insufficiency, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
- 20
- Study locations
NCT03227757 is a NA study of Tricuspid Valve Insufficiency that has completed, run by Abbott Medical Devices. The registered enrollment target is 98 participants, below the 329-participant average among 6 other Tricuspid Valve Insufficiency trials with a reported enrollment target (70% lower). The trial reports 20 study locations across 13 states.
The verdict
NCT03227757, a NA study of Tricuspid Valve Insufficiency, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary purpose of this study is to evaluate safety and effectiveness of the Tricuspid Valve Repair System (TVRS) for treating symptomatic moderate or greater tricuspid regurgitation (TR) in patients currently on medical management and who are deemed appropriate for percutaneous transcatheter intervention.
Conditions Studied
Interventions
- DEVICE Tricuspid Valve Repair System
Study Locations (20)
Other
- Bichat-Claude Bernard Hospital - Paris
- Albertinen-Krankenhaus - Hamburg
- Hospital de Sant Pau - Barcelona
- Clinical and Provincial Hospital of Barcelona - Barcelona
- Inselspital Bern - Bern
- HerzKlinik Hirslanden - Klinik Hirslanden - Zurich
- University Hospital of Zurich (USZ) - Zurich
Milan
- San Raffaele University Hospital - Milan
- Istituto Clinico Sant'Ambrogio - Milan
California
- Cedars-Sinai Medical Center - Los Angeles
Michigan
- Henry Ford Hospital - Detroit
Minnesota
- Abbott Northwestern Hospital - Minneapolis
New York
- Mount Sinai Hospital - New York
Saint-Herblain
- Hospital Nord Laennec - Chu De Nantes - Nantes
Bavaria
- Ludwig-Maximilian University of Munich (LMU) - Munich
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2024-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03227757
The ClinicalTrials.gov registry entry for NCT03227757 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 329-participant average among 6 other Tricuspid Valve Insufficiency trials with a reported enrollment target (70% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tricuspid Valve Insufficiency appearing as the primary indexed condition, and to 1 intervention - of which Tricuspid Valve Repair System is the first listed.
NCT03227757 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Other, Milan, California.
Frequently Asked Questions
What is clinical trial NCT03227757 about?
NCT03227757 is a clinical study titled "TRILUMINATE Study With Abbott Transcatheter Clip Repair System in Patients With Moderate or Greater TR". The primary purpose of this study is to evaluate safety and effectiveness of the Tricuspid Valve Repair System (TVRS) for treating symptomatic moderate or greater tricuspid regurgitation (TR) in patients currently on medical management and who are deemed appropriate for percutaneous transcatheter in...
What is the current status of trial NCT03227757?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2017-08-01. Estimated completion is 2024-05-30.
What conditions does trial NCT03227757 study?
This clinical trial studies the following conditions: Tricuspid Valve Insufficiency.
What interventions are being tested in trial NCT03227757?
The interventions under investigation include: Tricuspid Valve Repair System (DEVICE).
Who is sponsoring clinical trial NCT03227757?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03227757 being conducted?
This trial has 20 study locations across California, Michigan, Minnesota, New York, Saint-Herblain. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tricuspid Valve Insufficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
RECRUITING · NA
-
CorMatrix Cor TRICUSPID ECM Valve Replacement - Pivotal Study
RECRUITING · NA
-
EFS of the DUO System for Tricuspid Regurgitation
RECRUITING · NA
-
NHLBI and Cook Trans-Atrial Intra-Pericardial Tricuspid Annuloplasty (TRAIPTA) Early Feasibility Study
RECRUITING · NA
-
TRISCEND II Pivotal Trial
ACTIVE NOT RECRUITING · NA
-
Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation Study
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.